Gene · 3021
Papers1,611
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,611
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Application of Single-Cell and Spatial Omics in Musculoskeletal Disorder Research. | Int J Mol Sci | 2023 | 36768592 | PubTator, text mining | PubMed |
| Histone variant H2A.Z modulates nucleosome dynamics to promote DNA accessibility. | Nat Commun | 2023 | 36765119 | PubTator, text mining | PubMed |
| Parallelized multidimensional analytic framework applied to mammary epithelial cells uncovers regulatory principles in EMT. | Nat Commun | 2023 | 36755019 | PubTator, text mining | PubMed |
| Developing H3K27M mutant selective radiosensitization strategies in diffuse intrinsic pontine glioma. | Neoplasia | 2023 | 36724689 | PubTator, text mining | PubMed |
| Profiling of peripheral blood B-cell transcriptome in children who developed coeliac disease in a prospective study. | Heliyon | 2023 | 36718152 | PubTator, text mining | PubMed |
| Dynamic changes in whole genome DNA methylation, chromatin and gene expression during mouse lens differentiation. | Epigenetics Chromatin | 2023 | 36698218 | PubTator, text mining | PubMed |
| Emerging TACnology: Heterobifunctional Small Molecule Inducers of Targeted Posttranslational Protein Modifications. | Molecules | 2023 | 36677746 | PubTator, text mining | PubMed |
| Post-Translational Modifications of Histone Variants in the Absence and Presence of a Methionine-Depleting Enzyme in Normal and Cancer Cells. | Cancers (Basel) | 2023 | 36672476 | PubTator, text mining | PubMed |
| Bottom-up proteomics analysis for adduction of the broad-spectrum herbicide atrazine to histone. | Anal Bioanal Chem | 2023 | 36662240 | PubTator, text mining | PubMed |
| Metaphyseal chondroblastoma in a pediatric patient. | Radiol Case Rep | 2023 | 36660567 | PubTator, text mining | PubMed |
| A knockout-first model of H3f3a gene targeting leads to developmental lethality. | Genesis | 2023 | 36656301 | PubTator, text mining | PubMed |
| Events in CNS Tumor Pathology Post-2016 WHO CNS: cIMPACT-NOW Updates and Other Advancements: A Comprehensive Review Plus a Summary of the Salient Features of 2021 WHO CNS 5. | Int J Gen Med | 2023 | 36644568 | PubTator, text mining | PubMed |
| Expression of SATB2, RUNX2, and SOX9 and possible osteoblastic and chondroblastic differentiation in chondroblastoma. | Pathol Res Pract | 2023 | 36442415 | PubTator, text mining | PubMed |
| Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification. | Acta Neuropathol | 2023 | 36437415 | PubTator, text mining | PubMed |
| Darinaparsin (ZIO-101) enhances the sensitivity of small-cell lung cancer to PARP inhibitors. | Acta Pharmacol Sin | 2023 | 36253561 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| Distal Femoral Non-Epiphyseal Cortical Chondroblastoma Confirmed with H3F3B p. Lys36Met Mutation. | Fetal Pediatr Pathol | 2023 | 36048092 | PubTator, text mining | PubMed |
Anti-histone H3.3K36M Antibody is a Highly Sensitive and Specific Immunohistochemistry Marker for the Diagnosis of Chondroblastoma. A Validation Based on Study 136 Cases Comprising Chondroblastoma and its Mimics from Single a Centre in India. | Int J Surg Pathol | 2023 | 35786027 | PubTator, text mining | PubMed |
| Perinatal exposure to pesticides alters synaptic plasticity signaling and induces behavioral deficits associated with neurodevelopmental disorders. | Cell Biol Toxicol | 2023 | 35137321 | PubTator, text mining | PubMed |
| The role of miR-128 in cancer development, prevention, drug resistance, and immunotherapy. | Front Oncol | 2022 | 36793341 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3021/papers?page=11